1887

Abstract

Infection with positive strains of is recognized as being associated with an increased risk of gastric cancer. This article reviews the current knowledge on the structures and pathological functions of and the CagA protein, focusing especially on the molecular mechanism through which CagA may be involved in gastric carcinogenesis. The possible link between the geographical distribution of and variations and gastric cancer diversity in Asia is also discussed.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.2008/003160-0
2008-12-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/12/1445.html?itemId=/content/journal/jmm/10.1099/jmm.0.2008/003160-0&mimeType=html&fmt=ahah

References

  1. Ali M., Khan A. A., Tiwari S. K., Ahmed N., Rao L. V., Habibullah C. M. 2005; Association between cag -pathogenicity island in Helicobacter pylori isolates from peptic ulcer, gastric carcinoma, and non-ulcer dyspepsia subjects with histological changes. World J Gastroenterol 11:6815–6822
    [Google Scholar]
  2. Amieva M. R., Vogelmann R., Covacci A., Tompkins L. S., Nelson W. J., Falkow S. 2003; Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300:1430–1434 [CrossRef]
    [Google Scholar]
  3. Argent R. H., Kidd M., Owen R. J., Thomas R. J., Limb M. C., Atherton J. C. 2004; Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori . Gastroenterology 127:514–523 [CrossRef]
    [Google Scholar]
  4. Atherton J. C., Cao P., Peek R. M. Jr, Tummuru M. K., Blaser M. J., Cover T. L. 1995; Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori . Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270:17771–17777 [CrossRef]
    [Google Scholar]
  5. Atherton J. C., Peek R. M. Jr, Tham K. T., Cover T. L., Blaser M. J. 1997; Clinical and pathological importance of heterogeneity in vacA , the vacuolating cytotoxin gene of Helicobacter pylori . Gastroenterology 112:92–99 [CrossRef]
    [Google Scholar]
  6. Azuma T., Yamazaki S., Yamakawa A., Ohtani M., Muramatsu A., Suto H., Ito Y., Dojo M., Yamazaki Y. other authors 2004; Association between diversity in the Src homology 2 domain – containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis 189:820–827 [CrossRef]
    [Google Scholar]
  7. Backert S., Meyer T. F. 2006; Type IV secretion systems and their effectors in bacterial pathogenesis. Curr Opin Microbiol 9:207–217 [CrossRef]
    [Google Scholar]
  8. Backert S., Ziska E., Brinkmann V., Zimny-Arndt U., Fauconnier A., Jungblut P. R., Naumann M., Meyer T. F. 2000; Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol 2:155–164 [CrossRef]
    [Google Scholar]
  9. Backert S., Moese S., Selbach M., Brinkmann V., Meyer T. F. 2001; Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol 42:631–644
    [Google Scholar]
  10. Bagnoli F., Buti L., Tompkins L., Covacci A., Amieva M. R. 2005; Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci U S A 102:16339–16344 [CrossRef]
    [Google Scholar]
  11. Balkwill F., Mantovani A. 2001; Inflammation and cancer: back to Virchow?. Lancet 357:539–545 [CrossRef]
    [Google Scholar]
  12. Basso D., Zambon C. F., Letley D. P., Stranges A., Marchet A., Rhead J. L., Schiavon S., Guariso G., Ceroti M. other authors 2008; Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135:91–99 [CrossRef]
    [Google Scholar]
  13. Brandt S., Kwok T., Hartig R., Konig W., Backert S. 2005; NF- κ B activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A 102:9300–9305 [CrossRef]
    [Google Scholar]
  14. Brenner H., Arndt V., Stegmaier C., Ziegler H., Rothenbacher D. 2004; Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer?. Am J Epidemiol 159:252–258 [CrossRef]
    [Google Scholar]
  15. Censini S., Lange C., Xiang Z., Crabtree J. E., Ghiara P., Borodovsky M., Rappuoli R., Covacci A. 1996; cag , a pathogenicity island of Helicobacter pylori , encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 93:14648–14653 [CrossRef]
    [Google Scholar]
  16. Chattopadhyay S., Datta S., Chowdhury A., Chowdhury S., Mukhopadhyay A. K., Rajendran K., Bhattacharya S. K., Berg D. E., Nair G. B. 2002; Virulence genes in Helicobacter pylori strains from West Bengal residents with overt H. pylori -associated disease and healthy volunteers. J Clin Microbiol 40:2622–2625 [CrossRef]
    [Google Scholar]
  17. Chaudhuri S., Chowdhury A., Datta S., Mukhopadhyay A. K., Chattopadhya S., Saha D. R., Dhali G., Santra A., Nair G. B. other authors 2003; Anti- Helicobacter pylori therapy in India: differences in eradication efficiency associated with particular alleles of vacuolating cytotoxin ( vacA ) gene. J Gastroenterol Hepatol 18:190–195 [CrossRef]
    [Google Scholar]
  18. Cheng A. M., Saxton T. M., Sakai R., Kulkarni S., Mbamalu G., Vogel W., Tortorice C. G., Cardiff R. D., Cross J. C. other authors 1998; Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 95:793–803 [CrossRef]
    [Google Scholar]
  19. Choi K. D., Kim N., Lee D. H., Kim J. M., Kim J. S., Jung H. C., Song I. S. 2007; Analysis of the 3′ variable region of the cagA gene of Helicobacter pylori isolated in Koreans. Dig Dis Sci 52:960–966 [CrossRef]
    [Google Scholar]
  20. Chomvarin C., Namwat W., Chaicumpar K., Mairiang P., Sangchan A., Sripa B., Tor-Udom S., Vilaichone R. K. 2008; Prevalence of Helicobacter pylori vacA , cagA , cagE , iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis 12:30–36 [CrossRef]
    [Google Scholar]
  21. Churin Y., Al-Ghoul L., Kepp O., Meyer T. F., Birchmeier W., Naumann M. 2003; Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol 161:249–255 [CrossRef]
    [Google Scholar]
  22. Coussens L. M., Werb Z. 2002; Inflammation and cancer. Nature 420:860–867 [CrossRef]
    [Google Scholar]
  23. Covacci A., Telford J. L., Del Giudice G., Parsonnet J., Rappuoli R. 1999; Helicobacter pylori virulence and genetic geography. Science 284:1328–1333 [CrossRef]
    [Google Scholar]
  24. Datta S., Chattopadhyay S., Balakrish Nair G., Mukhopadhyay A. K., Hembram J., Berg D. E., Rani Saha D., Khan A., Santra A. other authors 2003; Virulence genes and neutral DNA markers of Helicobacter pylori isolates from different ethnic communities of West Bengal, India. J Clin Microbiol 41:3737–3743 [CrossRef]
    [Google Scholar]
  25. De Souza D., Fabri L. J., Nash A., Hilton D. J., Nicola N. A., Baca M. 2002; SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities. Biochemistry 41:9229–9236 [CrossRef]
    [Google Scholar]
  26. Ekstrom A. M., Held M., Hansson L. E., Engstrand L., Nyren O. 2001; Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 121:784–791 [CrossRef]
    [Google Scholar]
  27. El-Etr S. H., Mueller A., Tompkins L. S., Falkow S., Merrell D. S. 2004; Phosphorylation-independent effects of CagA during interaction between Helicobacter pylori and T84 polarized monolayers. J Infect Dis 190:1516–1523 [CrossRef]
    [Google Scholar]
  28. Erzin Y., Koksal V., Altun S., Dobrucali A., Aslan M., Erdamar S., Dirican A., Kocazeybek B. 2006; Prevalence of Helicobacter pylorivacA , cagA , cagE , iceA , babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia. Helicobacter 11:574–580 [CrossRef]
    [Google Scholar]
  29. Falush D., Wirth T., Linz B., Pritchard J. K., Stephens M., Kidd M., Blaser M. J., Graham D. Y., Vacher S. other authors 2003; Traces of human migrations in Helicobacter pylori populations. Science 299:1582–1585 [CrossRef]
    [Google Scholar]
  30. Fischer W., Puls J., Buhrdorf R., Gebert B., Odenbreit S., Haas R. 2001; Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 42:1337–1348
    [Google Scholar]
  31. Fodde R., Brabletz T. 2007; Wnt/ β -catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19:150–158 [CrossRef]
    [Google Scholar]
  32. Forman D., Newell D. G., Fullerton F., Yarnell J. W., Stacey A. R., Wald N., Sitas F. 1991; Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302:1302–1305 [CrossRef]
    [Google Scholar]
  33. Franco A. T., Israel D. A., Washington M. K., Krishna U., Fox J. G., Rogers A. B., Neish A. S., Collier-Hyams L., Perez-Perez G. I. other authors 2005; Activation of β -catenin by carcinogenic Helicobacter pylori . Proc Natl Acad Sci U S A 102:10646–10651 [CrossRef]
    [Google Scholar]
  34. Fu H. Y., Asahi K., Hayashi Y., Eguchi H., Murata H., Tsujii M., Tsuji S., Azuma T., Kawano S. 2007; East Asian-type Helicobacter pylori cytotoxin-associated gene A protein has a more significant effect on growth of rat gastric mucosal cells than the Western type. J Gastroenterol Hepatol 22:355–362 [CrossRef]
    [Google Scholar]
  35. Ghose C., Perez-Perez G. I., Dominguez-Bello M. G., Pride D. T., Bravi C. M., Blaser M. J. 2002; East Asian genotypes of Helicobacter pylori strains in Amerindians provide evidence for its ancient human carriage. Proc Natl Acad Sci U S A 99:15107–15111 [CrossRef]
    [Google Scholar]
  36. Guillemin K., Salama N. R., Tompkins L. S., Falkow S. 2002; cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc Natl Acad Sci U S A 99:15136–15141 [CrossRef]
    [Google Scholar]
  37. Hatakeyama M. 2004; Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 4:688–694 [CrossRef]
    [Google Scholar]
  38. Hatakeyama M. 2006; Helicobacter pylori CagA – a bacterial intruder conspiring gastric carcinogenesis. Int J Cancer 119:1217–1223 [CrossRef]
    [Google Scholar]
  39. Higashi H., Tsutsumi R., Fujita A., Yamazaki S., Asaka M., Azuma T., Hatakeyama M. 2002a; Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A 99:14428–14433 [CrossRef]
    [Google Scholar]
  40. Higashi H., Tsutsumi R., Muto S., Sugiyama T., Azuma T., Asaka M., Hatakeyama M. 2002b; SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295:683–686 [CrossRef]
    [Google Scholar]
  41. Higashi H., Nakaya A., Tsutsumi R., Yokoyama K., Fujii Y., Ishikawa S., Higuchi M., Takahashi A., Kurashima Y. other authors 2004; Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem 279:17205–17216 [CrossRef]
    [Google Scholar]
  42. Higashi H., Yokoyama K., Fujii Y., Ren S., Yuasa H., Saadat I., Murata-Kamiya N., Azuma T., Hatakeyama M. 2005; EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J Biol Chem 280:23130–23137 [CrossRef]
    [Google Scholar]
  43. Hoppler S., Kavanagh C. L. 2007; Wnt signalling: variety at the core. J Cell Sci 120:385–393 [CrossRef]
    [Google Scholar]
  44. Huang J. Q., Zheng G. F., Sumanac K., Irvine E. J., Hunt R. H. 2003; Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125:1636–1644 [CrossRef]
    [Google Scholar]
  45. Ikenoue T., Maeda S., Ogura K., Akanuma M., Mitsuno Y., Imai Y., Yoshida H., Shiratori Y., Omata M. 2001; Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clin Diagn Lab Immunol 8:181–186
    [Google Scholar]
  46. Jamora C., Fuchs E. 2002; Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol 4:E101–E108 [CrossRef]
    [Google Scholar]
  47. Kanada R., Uchida T., Tsukamoto Y., Nguyen L. T., Hijiya N., Matsuura K., Kodama M., Okimoto T., Murakami K. other authors 2008; Genotyping of the cagA gene of Helicobacter pylori on immunohistochemistry with East Asian CagA-specific antibody. Pathol Int 58:218–225 [CrossRef]
    [Google Scholar]
  48. Karin M. 2006; Nuclear factor- κ B in cancer development and progression. Nature 441:431–436 [CrossRef]
    [Google Scholar]
  49. Kauser F., Khan A. A., Hussain M. A., Carroll I. M., Ahmad N., Tiwari S., Shouche Y., Das B., Alam M. other authors 2004; The cag pathogenicity island of Helicobacter pylori is disrupted in the majority of patient isolates from different human populations. J Clin Microbiol 42:5302–5308 [CrossRef]
    [Google Scholar]
  50. Kersulyte D., Mukhopadhyay A. K., Velapatino B., Su W., Pan Z., Garcia C., Hernandez V., Valdez Y., Mistry R. S. other authors 2000; Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol 182:3210–3218 [CrossRef]
    [Google Scholar]
  51. Kidd M., Lastovica A. J., Atherton J. C., Louw J. A. 1999; Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa?. Gut 45:499–502 [CrossRef]
    [Google Scholar]
  52. Kurashima Y., Murata-Kamiya N., Kikuchi K., Higashi H., Azuma T., Kondo S., Hatakeyama M. 2008; Deregulation of β -catenin signal by Helicobacter pylori CagA requires the CagA-multimerization sequence. Int J Cancer 122:823–831 [CrossRef]
    [Google Scholar]
  53. Maeda S., Yoshida H., Ikenoue T., Ogura K., Kanai F., Kato N., Shiratori Y., Omata M. 1999; Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 44:336–341 [CrossRef]
    [Google Scholar]
  54. Matsumoto Y., Marusawa H., Kinoshita K., Endo Y., Kou T., Morisawa T., Azuma T., Okazaki I. M., Honjo T. other authors 2007; Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 13:470–476 [CrossRef]
    [Google Scholar]
  55. Miehlke S., Kirsch C., Agha-Amiri K., Gunther T., Lehn N., Malfertheiner P., Stolte M., Ehninger G., Bayerdorffer E. 2000; The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer 87:322–327 [CrossRef]
    [Google Scholar]
  56. Mimuro H., Suzuki T., Tanaka J., Asahi M., Haas R., Sasakawa C. 2002; Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol Cell 10:745–755 [CrossRef]
    [Google Scholar]
  57. Miwa H., Go M. F., Sato N. 2002; H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol 97:1106–1112 [CrossRef]
    [Google Scholar]
  58. Moese S., Selbach M., Brinkmann V., Karlas A., Haimovich B., Backert S., Meyer T. F. 2007; The Helicobacter pylori CagA protein disrupts matrix adhesion of gastric epithelial cells by dephosphorylation of vinculin. Cell Microbiol 9:1148–1161 [CrossRef]
    [Google Scholar]
  59. Mukhopadhyay A. K., Kersulyte D., Jeong J. Y., Datta S., Ito Y., Chowdhury A., Chowdhury S., Santra A., Bhattacharya S. K. other authors 2000; Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India. J Bacteriol 182:3219–3227 [CrossRef]
    [Google Scholar]
  60. Murata-Kamiya N., Kurashima Y., Teishikata Y., Yamahashi Y., Saito Y., Higashi H., Aburatani H., Akiyama T., Peek R. M. Jr other authors 2007; Helicobacter pylori CagA interacts with E-cadherin and deregulates the β -catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 26:4617–4626 [CrossRef]
    [Google Scholar]
  61. Naito M., Yamazaki T., Tsutsumi R., Higashi H., Onoe K., Yamazaki S., Azuma T., Hatakeyama M. 2006; Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 130:1181–1190 [CrossRef]
    [Google Scholar]
  62. Neel B. G., Gu H., Pao L. 2003; The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28:284–293 [CrossRef]
    [Google Scholar]
  63. Nilsson C., Sillen A., Eriksson L., Strand M. L., Enroth H., Normark S., Falk P., Engstrand L. 2003; Correlation between cag pathogenicity island composition and Helicobacter pylori -associated gastroduodenal disease. Infect Immun 71:6573–6581 [CrossRef]
    [Google Scholar]
  64. Odenbreit S., Puls J., Sedlmaier B., Gerland E., Fischer W., Haas R. 2000; Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497–1500 [CrossRef]
    [Google Scholar]
  65. Ogiwara H., Graham D. Y., Yamaoka Y. 2008; vacA i-region subtyping. Gastroenterology 134: 1267 [CrossRef]
    [Google Scholar]
  66. Parkin D. M. 2001; Global cancer statistics in the year 2000. Lancet Oncol 2:533–543 [CrossRef]
    [Google Scholar]
  67. Parkin D. M. 2004; International variation. Oncogene 23:6329–6340 [CrossRef]
    [Google Scholar]
  68. Parkin D. M. 2006; The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030–3044 [CrossRef]
    [Google Scholar]
  69. Parkin D. M., Bray F., Ferlay J., Pisani P. 2005; Global cancer statistics, 2002. CA Cancer J Clin 55:74–108 [CrossRef]
    [Google Scholar]
  70. Parsons J. T. 2003; Focal adhesion kinase: the first ten years. J Cell Sci 116:1409–1416 [CrossRef]
    [Google Scholar]
  71. Peruzzi B., Bottaro D. P. 2006; Targeting the c-Met signaling pathway in cancer. Clin Cancer Res 12:3657–3660 [CrossRef]
    [Google Scholar]
  72. Ren S., Higashi H., Lu H., Azuma T., Hatakeyama M. 2006; Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. J Biol Chem 281:32344–32352 [CrossRef]
    [Google Scholar]
  73. Rhead J. L., Letley D. P., Mohammadi M., Hussein N., Mohagheghi M. A., Eshagh Hosseini M., Atherton J. C. 2007; A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133:926–936 [CrossRef]
    [Google Scholar]
  74. Rieder G., Merchant J. L., Haas R. 2005; Helicobacter pylori Cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology 128:1229–1242 [CrossRef]
    [Google Scholar]
  75. Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., Lu H., Ohnishi N., Azuma T. other authors 2007; Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447:330–333 [CrossRef]
    [Google Scholar]
  76. Salih B. A., Abasiyanik M. F., Ahmed N. 2007; A preliminary study on the genetic profile of cag pathogenicity-island and other virulent gene loci of Helicobacter pylori strains from Turkey. Infect Genet Evol 7:509–512 [CrossRef]
    [Google Scholar]
  77. Saribasak H., Salih B. A., Yamaoka Y., Sander E. 2004; Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J Clin Microbiol 42:1648–1651 [CrossRef]
    [Google Scholar]
  78. Satomi S., Yamakawa A., Matsunaga S., Masaki R., Inagaki T., Okuda T., Suto H., Ito Y., Yamazaki Y. other authors 2006; Relationship between the diversity of the cagA gene of Helicobacter pylori and gastric cancer in Okinawa, Japan. J Gastroenterol 41:668–673 [CrossRef]
    [Google Scholar]
  79. Segal E. D., Cha J., Lo J., Falkow S., Tompkins L. S. 1999; Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori . Proc Natl Acad Sci U S A 96:14559–14564 [CrossRef]
    [Google Scholar]
  80. Selbach M., Moese S., Hauck C. R., Meyer T. F., Backert S. 2002; Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 277:6775–6778 [CrossRef]
    [Google Scholar]
  81. Selbach M., Moese S., Hurwitz R., Hauck C. R., Meyer T. F., Backert S. 2003; The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J 22:515–528 [CrossRef]
    [Google Scholar]
  82. Selbach M., Moese S., Backert S., Jungblut P. R., Meyer T. F. 2004; The Helicobacter pylori CagA protein induces tyrosine dephosphorylation of ezrin. Proteomics 4:2961–2968 [CrossRef]
    [Google Scholar]
  83. Singh K., Ghoshal U. C. 2006; Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol 12:1346–1351
    [Google Scholar]
  84. Stein M., Rappuoli R., Covacci A. 2000; Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag -driven host cell translocation. Proc Natl Acad Sci U S A 97:1263–1268 [CrossRef]
    [Google Scholar]
  85. Stein M., Bagnoli F., Halenbeck R., Rappuoli R., Fantl W. J., Covacci A. 2002; c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol 43:971–980 [CrossRef]
    [Google Scholar]
  86. Tomb J. F., White O., Kerlavage A. R., Clayton R. A., Sutton G. G., Fleischmann R. D., Ketchum K. A., Klenk H. P., Gill S. other authors 1997; The complete genome sequence of the gastric pathogen Helicobacter pylori . Nature 388:539–547 [CrossRef]
    [Google Scholar]
  87. Tsukashita S., Kushima R., Bamba M., Nakamura E., Mukaisho K., Sugihara H., Hattori T. 2003; β -Catenin expression in intramucosal neoplastic lesions of the stomach. Comparative analysis of adenoma/dysplasia, adenocarcinoma and signet-ring cell carcinoma. Oncology 64:251–258 [CrossRef]
    [Google Scholar]
  88. Tsutsumi R., Higashi H., Higuchi M., Okada M., Hatakeyama M. 2003; Attenuation of Helicobacter pylori CagA SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J Biol Chem 278:3664–3670 [CrossRef]
    [Google Scholar]
  89. Tsutsumi R., Takahashi A., Azuma T., Higashi H., Hatakeyama M. 2006; Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol Cell Biol 26:261–276 [CrossRef]
    [Google Scholar]
  90. Uchida T., Kanada R., Tsukamoto Y., Hijiya N., Matsuura K., Yano S., Yokoyama S., Kishida T., Kodama M. other authors 2007; Immunohistochemical diagnosis of the cagA -gene genotype of Helicobacter pylori with anti-East Asian CagA-specific antibody. Cancer Sci 98:521–528 [CrossRef]
    [Google Scholar]
  91. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., Schlemper R. J. 2001; Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789 [CrossRef]
    [Google Scholar]
  92. Viala J., Chaput C., Boneca I. G., Cardona A., Girardin S. E., Moran A. P., Athman R., Memet S., Huerre M. R. other authors 2004; Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5:1166–1174 [CrossRef]
    [Google Scholar]
  93. Vilaichone R. K., Mahachai V., Tumwasorn S., Wu J. Y., Graham D. Y., Yamaoka Y. 2004; Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter 9:453–459 [CrossRef]
    [Google Scholar]
  94. Yamaoka Y., Kita M., Kodama T., Sawai N., Kashima K., Imanishi J. 1997; Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41:442–451 [CrossRef]
    [Google Scholar]
  95. Yamaoka Y., Orito E., Mizokami M., Gutierrez O., Saitou N., Kodama T., Osato M. S., Kim J. G., Ramirez F. C. other authors 2002; Helicobacter pylori in North and South America before Columbus. FEBS Lett 517:180–184 [CrossRef]
    [Google Scholar]
  96. Zhou J., Zhang J., Xu C., He L. 2004a; cagA genotype and variants in Chinese Helicobacter pylori strains and relationship to gastroduodenal diseases. J Med Microbiol 53:231–235 [CrossRef]
    [Google Scholar]
  97. Zhou W., Yamazaki S., Yamakawa A., Ohtani M., Ito Y., Keida Y., Higashi H., Hatakeyama M., Si J. other authors 2004b; The diversity of vacA and cagA genes of Helicobacter pylori in East Asia. FEMS Immunol Med Microbiol 40:81–87 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.2008/003160-0
Loading
/content/journal/jmm/10.1099/jmm.0.2008/003160-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error